Biaxin, or clarithromycin, combats bacterial infections by binding to the 50S ribosomal subunit. This prevents the bacteria from synthesizing proteins, halting their growth and ultimately killing them. This mechanism is particularly effective against a range of bacteria commonly causing sinus infections.
Common Bacteria Targeted by Biaxin
Biaxin effectively targets several bacterial species frequently responsible for sinusitis. These include Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. However, resistance to macrolides, the antibiotic class Biaxin belongs to, is a growing concern. Your doctor considers this when prescribing the medication.
Important Note on Bacterial Resistance
The effectiveness of Biaxin depends on the specific bacteria causing your sinus infection and its susceptibility to the antibiotic. A culture and sensitivity test may be necessary to confirm the appropriate treatment. Always consult a healthcare professional for accurate diagnosis and treatment. Misuse of antibiotics fuels resistance, so responsible use is critical.
